A Study to Examine Anktiva for the Treatment of COVID-19.
Summary:
Type:
Status:
Interventions:
Anktiva
Locations:
El Segundo, United States
Last Updated:
May 8, 2026
DMSO Dual-Route Therapy for Refractory Tinnitus in Long-COVID and Post-COVID-19 Vaccine Injury
Summary:
Type:
Status:
Interventions:
DMSO-based otic solution with betahistine, dexamethasone, and lidocaine, DMSO-based transdermal cream with levocarnitine and N-acetylcysteine
Locations:
Ithaca, United States
Last Updated:
May 8, 2026
A Study to Assess Anktiva in Patients With Long Covid-19.
Summary:
Type:
Status:
Interventions:
N-803 (IL-15 Superagonist)
Locations:
San Francisco, United States
Last Updated:
May 8, 2026
Cognitive-Sensorimotor Function in Long-COVID
Summary:
Type:
Status:
Locations:
Chicago, United States
Last Updated:
May 7, 2026
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
Summary:
Type:
Status:
Interventions:
Baricitinib, Placebo
Locations:
Tucson, United States; Los Angeles, United States; and 14 more
Last Updated:
May 7, 2026
A Study of Post COVID-19 Mechanisms for Chronic Lung Sequelae
Summary:
Type:
Status:
Locations:
Rochester, United States
Last Updated:
May 1, 2026
Low Dose Rapamycin in ME/CFS, Long-COVID, and Other Infection Associated Chronic Conditions
Summary:
Type:
Status:
Locations:
Palo Alto, United States; Rochester, United States; and 2 more
Last Updated:
April 30, 2026
Evaluating the Neuromodulatory Effect of Ketamine in Long COVID-19
Summary:
Type:
Status:
Interventions:
Ketamine only
Locations:
Austin, United States
Last Updated:
April 27, 2026
Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2
Summary:
Type:
Status:
Interventions:
IV normal saline, IV immunoglobulin
Locations:
Bethesda, United States
Last Updated:
April 27, 2026
Cross-Sectional Evaluation of Persistence of SARS-CoV-2 Remnants After Recovery From Acute Infection
Summary:
Type:
Status:
Locations:
Bethesda, United States
Last Updated:
April 16, 2026